BOONTON, N.J., March 11, 2013 /PRNewswire/ -- Unigene Laboratories, Inc. (UGNE) today announced financial results for the fourth quarter and full-year ended December 31, 2012 and provided a corporate update on the Company's financial status and the expected impact of the March 5, 2013 meeting of the Advisory Committee to the U.S. Food and Drug Administration.
